In addition, DLBCL patients with a dual rearrangement of MYC and BCL2, “double/triple-hit” lymphoma, were recognized as a high-grade category with a poor prognosis in the latest WHO and ICC classification [19, 20]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.